Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
- 15 September 1997
- journal article
- clinical trial
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 58 (9) , 399-401
- https://doi.org/10.4088/jcp.v58n0905
Abstract
Dysphoric premenstrual syndrome (PMS) has been associated with serotonergic dysregulation, and serotonergic medications have been reported to alleviate the symptoms of PMS. We investigated the effects of the serotonin reuptake inhibitor sertraline given during only the luteal phase in women with dysphoric PMS.Keywords
This publication has 0 references indexed in Scilit: